TWiV 730: COVID-19 clinical update #53 with Dr. Daniel Griffin
Mar 13, 2021•45 min•Ep. 730
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #53, Daniel Griffin reviews underreporting of infections and long term disease in children, a blood test for T cells, results of phase 3 trials for monoclonal antibodies, preliminary findings on an oral antiviral, clinical trial of ivermectin, and recommendations for upcoming gatherings.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- SARS-CoV-2 seroprevalence in
- EUA for T cell test (FDA)
- Lilly mAb phase 3 results (Lilly)
- VIR-7831 mAb phase 3 results (Globenewswire)
- Molnupiravir phase 2a results (Merck)
- Ivermectin not supported for mild COVID-19 (JAMA)
- Recommendations for fully vaccinated people (CDC)
- Letters read on TWiV 730
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android